Edit |   |
---|---|
Antigenic Specificity | TNFA, Human (Infliximab biosimilar) |
Clone | Infliximab |
Host Species | Recombinant Mouse |
Reactive Species | human |
Isotype | IgG1 kappa |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | IF, IP, Neut, FuncS, ELISA, FCM, WB |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human TNFA Recombinant Antibody (Infliximab). Infliximab, a chimeric monoclonal antibody, sold under the brand name Remicade among others, is a medication used to treat a number of autoimmune diseases. This includes Crohn's disease, ulcerative colitis, rheumatoid arthritis, ankylosing spondylitis, psoriasis, psoriatic arthritis, and Behcet's disease. |
Immunogen | n/a |
Other Names | Anti-TNFA Recombinant Antibody, Research Grade Infliximab, Anti-Human TNFA Recombinant Antibody(Infliximab), TA-650, cA2, Antibody Drug Analogues, Monoclonal Antibody, YR1094, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 170277-31-3 |
Catalog # | YR1094 |
Price | please inquire |
Order / More Info | TNFA, Human (Infliximab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |